Jurgi Camblong
| Jurgi Camblong | |
|---|---|
| File:SOPHIA GENETICS - SHOOTING - CEO.pngSOPHIA GENETICS - SHOOTING - CEO.png Jurgi Camblong in 2020 | |
| Born | March 15, 1978 Bayonne, France |
| 🎓 Alma mater | University of Geneva (PhD) |
| 💼 Occupation | Entrepreneur, CEO of Sophia Genetics |
Jurgi Camblong (/juːrgɪ kɒmblɒn/, born March 15, 1978 in Bayonne, France) is a molecular biologist, expert in data-driven medicine and CEO of Sophia Genetics.[1]
Career
Jurgi Camblong was born in Bayonne in the French Basque Country. He holds a PhD in Life Sciences from the University of Geneva, and an EMBA in Management of Technology from EPFL and HEC Lausanne.[1] In 2008, he moved to the University of Oxford as a post-doctoral researcher at the Sir William Dunn School of Pathology.[2][3]
Jurgi Camblong was a member of the Advisory Council "Digital Transformation" of the Swiss Government.[4]
Sophia Genetics
Jurgi Camblong founded Swiss-based Sophia Genetics in 2011, a health-tech company whose purpose is to democratize data-driven medicine.[1][2]
The company specializes in the analysis of genomic data and developed Sophia, a platform based on artificial intelligence, which transforms patients' clinical data into information that can be used by healthcare professionals to understand the cause behind diseases.[5] In addition to genomic data, the platform aggregates and analyzes radiomic data to help diagnose patients with cancer and rare genetic disorders, monitor cancer progression and treatment success, and guide precision treatment.[6]
Under the aegis of Jurgi Camblong, Sophia Genetics has won a number of innovation awards[7][8] and raised several hundred million US dollars in successive fundraisings.[9][10]
In 2018, the company opened its US headquarters in Boston, Massachusetts.[11]
Recognition
In 2017, Jurgi Camblong received the EY Emerging Entrepreneur of the Year Award.[12]
Publications
- Camblong, Jurgi; Iglesias, Nahid; Fickentscher, Céline; Dieppois, Guennaelle; Stutz, Françoise (2007). "Antisense RNA Stabilization Induces Transcriptional Gene Silencing via Histone Deacetylation in S. Cerevisiae". Cell. 131 (4): 706–717. doi:10.1016/j.cell.2007.09.014. PMID 18022365. Unknown parameter
|s2cid=ignored (help) - Camblong, J.; Beyrouthy, N.; Guffanti, E.; Schlaepfer, G.; Steinmetz, L. M.; Stutz, F. (2009). "Trans-acting antisense RNAs mediate transcriptional gene cosuppression in S. Cerevisiae". Genes & Development. 23 (13): 1534–1545. doi:10.1101/gad.522509. PMC 2704465. PMID 19571181.
References
- ↑ 1.0 1.1 1.2 "Interview with Dr. Jurgi Camblong on democratization of medicine and AI". Big Data Made Simple. 2019-01-29. Archived from the original on 2020-10-13. Retrieved 2021-01-14.
- ↑ 2.0 2.1 Banks, Linda (2015-05-14). "7 Questions: Jurgi Camblong on data-driven medicine -". pharmaphorum.com. Retrieved 2021-01-14.
- ↑ Tan-Wong, Sue Mei; Zaugg, Judith B.; Camblong, Jurgi; Xu, Zhenyu; Zhang, David W.; Mischo, Hannah E.; Ansari, Aseem Z.; Luscombe, Nicholas M.; Steinmetz, Lars M.; Proudfoot, Nick J. (2012-11-02). "Gene loops enhance transcriptional directionality". Science. 338 (6107): 671–675. Bibcode:2012Sci...338..671T. doi:10.1126/science.1224350. ISSN 1095-9203. PMC 3563069. PMID 23019609.
- ↑ "Advisory Council on Digital Transformation includes people with start-up experience Startupticker.ch | The Swiss Startup News channel". www.startupticker.ch. Retrieved 2021-01-14.
- ↑ Burgess, Matt (2017-03-09). "This AI doctor knows what's wrong with you by checking your genome". Wired UK. ISSN 1357-0978. Retrieved 2021-01-14.
- ↑ "Sophia Genetics taps ex-Foundation Medicine CEO as chairman". FierceBiotech. Retrieved 2021-01-14.
- ↑ "What are the 50 Smartest Companies?". MIT Technology Review. Retrieved 2021-01-14.
- ↑ "The World's Most Innovative Companies 2018: Biotech Honorees". Fast Company. Retrieved 2021-01-14.
- ↑ "Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its 'data-driven medicine'". TechCrunch. Retrieved 2021-01-14.
- ↑ "Combining machine learning tools for medical imaging with genetic sequencing nets Sophia Genetics $110M". TechCrunch. Retrieved 2021-01-14.
- ↑ September 24; 2018; Comments, 8:36 p m Email to a Friend Share on Facebook Share on TwitterPrint this Article View. "Swiss company sets up US headquarters in Boston - The Boston Globe". BostonGlobe.com. Retrieved 2021-01-14.
- ↑ "Jurgi Camblong and Thomas Hanan win EY Entrepreneur Of The Year Award Startupticker.ch | The Swiss Startup News channel". www.startupticker.ch. Retrieved 2021-01-14.
External links
This article "Jurgi Camblong" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Jurgi Camblong. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
